Clinical Trials

NCT IdNCT04833959
TitlePilot Study of 89-Zr Panitumumab in Pancreas Cancer
ConditionPancreas Cancer
StudyTypeInterventional
OrganizationStanford University
Sponsor/CollaboratorsStanford University
StatusRecruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • Stanford University, Stanford, 94305 , United States
DescriptionThe main purpose of the study is to assess the safety of 89Zr-panitumumab as a molecular imaging agent in patients with (metastatic) pancreas cancer.